SHOULDER INNOVATIONS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SHOULDER INNOVATIONS, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $423.00K, a 255.46% increase year-over-year.
- SHOULDER INNOVATIONS, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $101.00K, a 215.63% increase year-over-year.
- SHOULDER INNOVATIONS, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $537.00K, a 713.64% increase year-over-year.
- SHOULDER INNOVATIONS, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $119.00K.
- SHOULDER INNOVATIONS, INC. stock issued during period, value, new issues for fiscal 2025 was $919.00K, a 1292.42% increase from fiscal 2024.
- SHOULDER INNOVATIONS, INC. stock issued during period, value, new issues for fiscal 2024 was $66.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $423.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $101.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $919.00K 10-K · filed 2026-03-10 | |
| 2025-09-30 | $537.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $119.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $32.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $66.00K 10-K · filed 2026-03-10 | |
| 2024-09-30 | $66.00K 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |